4
Changes in Ownership
Arcturus Therapeutics Holdings Inc. Filed Acc 0001209191-20-031641
Director acquired 600,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. Director | 2020-05-20 | Option exercise | +600,000 | $16.00 | $9,600,000 | 3,000,000 | D |
| Derivatives | |||||||
| Ultragenyx Pharmaceutical Inc. Director | 2020-05-20 | Option exercise · Option (Right to Buy) | −600,000 | 0 | D | ||
Loading xslF345X03/doc4.xml…